Dr. Morag Park, Goodman Cancer Research Centre

March 8, 2017
Dr. Morag Park awarded the prestigious Robert L. Noble Prize
Dr. Morag Park, Director of the Goodman Cancer Research Centre and Professor of Biochemistry, Medicine and Oncology, is the recipient of the Canadian Cancer Society 2017 Robert L. Noble Prize. 
The Canadian Cancer Society has honoured Dr. Park for her role as a leader in Canadian cancer research, being widely recognized for identifying key events in cancer development and the importance of a tumour’s surroundings for cancer growth, as well as her exceptional leadership in establishing national cancer research strategies.
Read the entire Med e-News article
Read the Canadian Cancer Society announcement


Dr. Nahum Sonenberg, Goodman Cancer Research Centre

March 3, 2017
Canada Foundation for Innovation awards McGill researchers over $4.5 million for state-of-the-art research equipment and facilities.
The Canadian Foundation for Innovation Award was established to support Canada’s top researchers to innovate, as well as to attract and retain top research talent, by giving them access to cutting-edge research equipment, laboratories and tools.
The GCRC proudly congratulates Dr. Nahum Sonenberg for receiving this prestigious award.
Read more


March 3, 2017
Congratulations Dr. Nicole Beauchemin for her role in the collaborative project that was awarded Québec Science’s “Découverte de l’année 2016 – Prix du public”

Professor Sylvain Martel of École Polytechnique de Montreal’s Nanorobotics laboratory has pioneered an approach using special bacteria that can be directed by a magnetic field to deliver chemotherapy directly to the site of tumors, reducing side-effects.
With the support of a team of co-investigators from McGill University (Drs. Te Vuong, Gerald Batist, Maryam Tabrizian, Nicole Beauchemin, Danuta Radzioch), the Université de Montréal (Dr. Louis Gaboury, Dr. Michel Lafleur), and with the support of a generous grant from CQDM, Dr. Martel and his team have demonstrated proof-of- concept as well as efficacy and lack of toxicity of this new technique using primary colorectal cancer cells.
This novel approach holds significant promise for improving cancer targeting with chemotherapy.

Read Québec Science Article
Read the Med e-News Article


March 3, 2017
This day marks the 25th anniversary of the Tremblay Lab!
Since 1992, Dr. Tremblay and his lab members have helped put the GCRC on the global map of discovery and innovation.
Over 60 researchers, students, postdoctoral fellows and supporting staff have been or are currently committed to the Tremblay Lab research projects. New discoveries are on the horizon for the Tremblay Lab - that will lead to the development of novel treatments for a broad range of human diseases including diabetes, obesity, spinal cord injury and infectious diseases as well as in diverse cancers.
Congratulations to Dr. Tremblay and all his lab members, past and present!


Dr. Jose Teodoro, Goodman Cancer Research Centre

March 3, 2017
The Teodoro Lab celebrates 10 Years!
It has been already 10 years since the Teodoro laboratory started its adventure. Our lab has had many achievements during this decade, including contributions to at least 20 papers and two PhD thesis defenses. We have also enriched the education of many undergraduate students by training them in proper research methods. We have a friendly working environment, which is led by an expert scientist who encourages us and helps us take control of our own future. We are hoping that our lab will continue to investigate exciting new research areas for many more years to come.
Teodoro Lab Members


February 2017
Congratulations to Dr. Jose Teodoro and his team for their latest publication in Cell Reports
This article reports that 53BP1 is a mitotic APC/C substrate and an interphase inhibitor. 53BP1 silencing leads to a hyperactive APC/C, resulting in cell cycle defects and sensitivity to mitotic poisons. This helps to explain observations that 53BP1 null mice display aneuploidy and cancer susceptibility.
Reciprocal Regulation between 53BP1 and the Anaphase-Promoting Complex/Cyclosome Is Required for Genomic Stability during Mitotic Stress
Thomas J. Kucharski, Paul E. Minshall, Mohamed Moustafa-Kamal, Andrew S. Turnell, Jose G. Teodoro


The Journal of Biological Chemistry, Michel L Tremblay

January 20, 2017
GCRC on the Front Cover of Research
The cover page from the Journal of Biological Chemistry 292, 786-801 of January 20, 2017 was generated by Dr. Alfonso Martinez de la Cruz (BioGune Institute in Bilbao, Spain) and Dr. Noriko Uetani (Tremblay’s lab GCRC). It represents the first structure of the CNNM2 CBS domain with the protein tyrosine phosphatase PRL-1. The complex is shown over a stain section of human breast cancer. The importance of this complex relates to its almost universal contribution in sustaining the high metabolism needed by cancer cells during proliferation and specially in the process of metastasis. Knowing the intimate structure of this complex allows us to move ahead in the development of exquisitely sensitive small molecule disruptors as a new class of therapeutics in many types of human cancers.  Read more

The Journal of Biological Chemistry, Michel L Tremblay

January 20, 2017
GCRC on the Front Cover of Research
The cover page from the Journal of Biological Chemistry 292, 786-801 of January 20, 2017 was generated by Dr. Alfonso Martinez de la Cruz (BioGune Institute in Bilbao, Spain) and Dr. Noriko Uetani (Tremblay’s lab GCRC). It represents the first structure of the CNNM2 CBS domain with the protein tyrosine phosphatase PRL-1. The complex is shown over a stain section of human breast cancer. The importance of this complex relates to its almost universal contribution in sustaining the high metabolism needed by cancer cells during proliferation and specially in the process of metastasis. Knowing the intimate structure of this complex allows us to move ahead in the development of exquisitely sensitive small molecule disruptors as a new class of therapeutics in many types of human cancers.  Read more


Dr. William Muller, Goodman Cancer Research Centre

December 2, 2016
The Honorable Kirsty Duncan, Minister of Science, announced 203 new and renewed Canada Research Chairs (CRC) at universities across Canada. Congratuations Dr. William Muller, who received the Tier 1 Renewal – Canada Research Chair in Molecular Oncology
Dr. William Muller's work to date has focused on elucidating the molecular mechanism by which oncogenes - genes that turn normal cells into tumorous cells - are involved in inducing breast cancer in a murine system. He has also developed a large series of transgenic animals that have allowed him to address the effects of various signalling and growth factors in the development of malignancy. As Canada Research Chair in Molecular Oncology, Dr. Muller plans to continue to investigate the interrelationship between distinct hormone, growth factor and signalling pathways in the induction of breast cancer. Read more


November 16, 2016
Unique mechanism for vinca site tubulin binding drug DZ-2384 without neurotoxicity – a major advancement for microtubule targeting agents.
In 2013, Diazon Pharmaceuticals teamed up with The Laboratory for Therapeutic Development (LTD) to identify the mechanism of action of a potential new anticancer agent called DZ-2384.  Members of the LTD, Dr. Joseph Tcherkezian, Cynthia Bernier, Dr. Yannève Rolland and Claude Godbout carried out functional genomic screens to identify the anti-mitotic mechanism.  They then went on to characterize its unique effects on microtubule dynamics compared with other anti-mitotics as well as to determine the activity of the compound in several mouse tumor models.  The study, published in Science Translational Medicine, was led by Drs. Anne Roulston and Gordon Shore along with Dr. Gary Brouhard Dept of Biology, and includes as collaborators GCRC members Drs. Peter Siegel and George Zogopoulos as well as several international labs.In 2013, Diazon Pharmaceuticals teamed up with The Laboratory for Therapeutic Development (LTD) to identify the mechanism of action of a potential new anticancer agent called DZ-2384.  Members of the LTD, Dr. Joseph Tcherkezian, Cynthia Bernier, Dr. Yannève Rolland and Claude Godbout carried out functional genomic screens to identify the anti-mitotic mechanism.  They then went on to characterize its unique effects on microtubule dynamics compared with other anti-mitotics as well as to determine the activity of the compound in several mouse tumor models.  The study, published in Science Translational Medicine, was led by Drs. Anne Roulston and Gordon Shore along with Dr. Gary Brouhard Dept of Biology, and includes as collaborators GCRC members Drs. Peter Siegel and George Zogopoulos as well as several international labs.   Read more


The Goodman Cancer Student Society & the Biochemistry Graduate Student Society
Career Development Day
Learn from the experts 1-4 pm
Professional development workshops for the skills you need
Career Planning: CV building, Individual career planning, Professional communication
Transferable Skills: Statistics, Academic job search, Public speaking
Research skills: High thru-put screens, Clinical samples, Big data

Spotlight 4-5pm
Emily Bell, PhD

Manager / Professional skills specialist | Desjardins Centre for Advanced Training of the RI-MUHC
“Preparing for a career after graduate school: what to do and when?”

“Speed dating” with the pros 5-8pm
Network with professionals currently employed across the biomedical industry for a “speed dating” style wine & cheese.
Features mostly McGill alumni!

Date: Friday, November 18, 2016 
Location: Goodman Cancer Research Centre and the Bellini Complex  Detals and registration


Friday, October 21st, 2016
Dr. Jerry Pelletier | New member of McGill's Quarter Century Club
Congratulations to Dr. Jerry Pelletier on his 25 years of service at McGill University.   


Friday, September 23th, 2016
New mechanism for spread of breast cancer identified
Congratulations to Dr. Charles Rajadurai and Dr. Morag Park on their study, in collaboration with the Massachusetts Institute of Technology, published recently in the Journal of Cell Biology that identifiies a new mechanism for the metastatic spread of breast cancer involving the enzyme SHIP2. The discovery is of particular importance given that SHIP2 is a drug target for which new molecular inhibitors are already in development.   Read more


Wednesday, September 21th, 2016
The Tumor Microenvironment- Methods and Protocols
Congratulations to Drs Nicole Beauchemin and Josie Ursini-Siegel on the launch of their new book that features cutting-edge methods and protocols for tumor microenvironment research.   Read more


Monday, September 19th, 2016
The miR-17∼92 microRNA Cluster Is a Global Regulator of Tumor Metabolism
Congratulations Graduate Student Said Izreig from the labs of Thomas Duchaine and Rusty Jones for his latest paper in Cell Reports.   Read more


Friday, September 16th, 2016
Fledgling network brings together McGill’s stem cell researchers
This article, featuring Professor Michel L Tremblay,  highlights what the McGill University scientific community is doing in stem cell research.   Read more


Sunday, September 18th, 2016
Join us for the Terry Fox Run
To join the team or donate to a runner, please visit the GCRC Foxtrotters team page  Read more


Monday, August 15th, 2016
Legions of nanorobots target cancerous tumours with precision
Researchers from Polytechnique Montréal, Université de Montréal, the Goodman Cancer Research Centre and McGill University have just achieved a spectacular breakthrough in cancer research. They have developed new nanorobotic agents capable of navigating through the bloodstream to administer a drug with precision by specifically targeting the active cancerous cells of tumours. This way of injecting medication ensures the optimal targeting of a tumour and avoids jeopardizing the integrity of organs and surrounding healthy tissues. As a result, the drug dosage that is highly toxic for the human organism could be significantly reduced.  Read more


cihr-irsc

July 2016
Congratulations to GCRC researchers who received CIHR 2016 Project Grants
Peter Siegel:  "Metabolic Adaptations During Breast Cancer Metastasis"
Julie St-Pierre"ShcA-coupled receptor tyrosine kinase signaling exposes PGC1a-dependent metabolic vulnerabilities in cancer progression and therapy"
Visit the CIHR website for project details


cihr-irsc

July  2016
Congratulations to GCRC researchers who received CIHR 2016 Foundation Scheme grants
Philippe Gros; "Genetic analysis of susceptibility to infections and to inflammation"
William Muller: "Oncogene-mediated signal transduction in transgenic mouse models of human breast cancer"
Jerry Pelletier:  "Targeting Deregulated Translational Control in Cancer"
Nahum Sonenberg: "Investigating mRNA translational control in the quest to cure human disease." 
Visit the CIHR website for project details


Tuesday, June 12th, 2016
Congratulations to Dr. Vincent Giguère and trainee Geneviève Deblois, for their recent publication in Nature Communications
Despite the initial benefits of treating HER2-amplified breast cancer patients with the tyrosine kinase inhibitor lapatinib, resistance inevitably develops. Geneviève Deblois, a trainee in Dr. Vincent Giguère’s group, assembled a team of researchers from six different laboratories affiliated with the GCRC to find the mechanisms leading to resistance to this drug in HER-2 positive breast cancer.  Read More   Link to Publication


Dr. Dr. Philippe Gros, Goodman Cancer Research Centre

Thursday, June 30th, 2016
Congratulations to Dr. Philippe Gros for his appointment to the Order of Canada.
Established in 1967 by Her Majesty Queen Elizabeth II, the Order of Canada is the cornerstone of the Canadian Honours System, and recognizes outstanding achievement, dedication to the community and service to the nation.

Philippe Gros, O.C. received this honour for his pioneering use of molecular genetics to identify risk factors in a range of conditions, including infectious diseases and cancer, and for his leadership in the health sciences.   Article in the McGill Reporter


Monday, June 6th, 2016
Dr. Pelletier's publication 'Using CRISPR to validate drug-target interactions' is featured on the cover of Cell Reports
Precise genome engineering for validation of drug mechanism. Chu et al. use CRISPR/Cas9 to demonstrate that inhibition of eukaryotic initiation factor (eIF) 4A by rocaglates is responsible for their in vivo anti-neoplastic activity. The gears represent mechanism of action with the laser denoting precise targeting of a critical component, eIF4A.  Artwork by Dr. Noriko Uetani.

Article


Monday, June 6th, 2016
Dr. Philip Branton receives the McGill University Medal for Exceptional Academic Achievement
Established in 2009, the McGill University Medal for Exceptional Academic Achievement is awarded to retired members of McGill’s academic staff who are uniquely deserving in light of their exceptional contributions to their discipline, to the University and to society at large.

The Goodman Cancer Research Centre is proud to congratulate Dr. Branton for his achievement.

Read the McGill Reporter article.


Sunday, June 5th, 2016
Three of the Centre’s renowned researchers were presented with prestigious awards in recognition of their outstanding work.
Congratulations to GCRC researchers who were honoured at the 4th biennial Goodman Gala:
Dr. Nicole Beauchemin, who was presented with the Limelight Award for her commitment to colon cancer research and her dedication to the Centre’s public outreach forums.
Dr. Nahum Sonenberg, who was presented with the Leadership Impact Award for his longstanding leadership in cancer research. Dr. Sonenberg was the 2014 recipient of the prestigious Wolf Prize, generally regarded as a precursor to the Nobel Prize.
Dr. Ian Watson, who was presented with the Future is Bright Award for his leadership in melanoma genomics research.

 


Sunday, June 5th, 2016
Goodman Cancer Research Gala raises $2.1 million
T
he 4th Goodman Cancer Research Gala has raised more than $2.1 million to fund foundational research, more effective diagnostic tools and the development of new treatments and therapies for cancer patients.

Read the Med e-News article.


Dr. Luke McCaffrey, Goodman Cancer Research Centre

May 20, 2016
Dr. Luke McCaffrey receives tenure
The Goodman Cancer Research Centre is proud to congratulate Associate Professor Luke McCaffrey for achieving tenure and promotion.   

 


Dr. Philip Branton, Goodman Cancer Research Centre

Friday, May 27th, 2016
A symposium in honour of Professor Philip E. Branton
Friday, May 27th, 2016 | 13:00 - 17:45
Sponsored by the Depts. of Biochemistry and Oncology and the Goodman Cancer Research Centre
"What we have learned about cancer over the past 40 years, and what we still do not know"
DateFriday, May 27th, 2016 | 13:00 -  17:45 
Location: McGill University Faculty Club                    Poster


Tuesday, May 10, 2016
Wear your favourite jeans on National Denim Day 2016
On Tuesday, May 10th, wear your favourite jeans and the CURE Foundation’s pink ribbon in support of National Denim Day, a fundraiser for breast cancer research.

Read More 

 


Thursday, May 5th, 2016
Defi Canderel 2016
On Thursday May 5th, 2016 More than 1000 SUPERHEROES will tighten their laces & run in the streets of MOntreal to join the fight against cancer!

Read More 

 


First authors of the study, David Papadopoli (l) of the St-Pierre lab and Etienne Audet-Walsh of the Giguère lab

January 15, 2016
GCRC Researchers uncover mechanism that makes cancer cells more susceptible to treatment
In a new study published in the journal Cell Reports, researchers at the Goodman Cancer Research Centre have uncovered a potential mechanism to make cancer cells more sensitive to chemotherapy.
Read the Med e-News Article


Monday, November 30, 2015
Dr. Nicole Beauchemin and Dr. Jerry Pelletier honoured at the 5th annual Gerald Bronfman Centre Symposium
The GCRC is proud to congratulate Dr. Nicole Beauchemin upon receiving the Lifetime Achievement Award
and Dr. Jerry Pelletier for receiving the Award for Research and Clinical Service at the 5th annual Gerald Bronfman Centre Symposium and Awards Ceremony.

Read more


Tuesday November 24th, 2015
Scientific Symposium Celebrating the 50th Anniversary Discovery of Carcinoembryonic antigen (CEA) Honouring Dr. Phil Gold and Dr. Samuel Freedman
 

Read more

In conversation with Dr. Phil Gold, pioneering cancer researcher


Monday, November 2, 2015
Dr. Park and Dr. Sonenberg honoured by CCRA
Two McGill researchers have been recognized for their efforts in ongoing fight against cancer. As announced earlier today, the Canadian Cancer Research Alliance (CCRA) has honoured four researchers with its annual awards. Morag Park has earned the CCRA’s award for Exceptional Leadership in Cancer Research while Nahum Sonenberg won the Outstanding Achievements in Cancer Research award. The official presentations will be made during the Canadian Cancer Research Conference on Nov. 8 and 9.
Article
 


Dr. Nahum Sonenberg, Goodman Cancer Research Centre

October 19, 2015
Dr. Nahum Sonenberg elected to the National Academy of Medicine
On October 19, the National Academy of Medicine, formerly the Institute of Medicine, announced the election of 70 regular members and 10 international members during its annual meeting. Among the inductees is Dr. Nahum Sonenberg, who was elected as an international member.
Read more

 


September 25, 2015
Congratulations GCRC Foxtrotters!
This year, the GCRC Foxtrotters raised $13,700 for the 35th Annual Terry Fox Run!
Read more

 


September 18, 2015
GCRC Receives $5.3M from the Terry Fox Foundation
In this 35th anniversary year of the Terry Fox Marathon of Hope, the GCRC TFRI team, led by Dr. Vincent Giguère, has been awarded $5.3 million to better understand how metabolic processes and pathways contribute to the growth and survival of cancer cells.
Read more

 


September 11, 2015
Julianna Blagih Chosen as Star-of-the-Month for July by FRQS
The GCRC is very proud to congratulate Julianna Blagih, of Dr. Jones' Laboratory, for receiving this honour, as a result of her
award-winning publication entitled, "The Energy Sensor AMPK Regulates T Cell and Metabolic Adaptation Effector Responses In Vivo."
Read more

 


Goodman Cancer Research Centre, Walk for Montreal, MUHC, Smart Palate Cookbook

June 22, 2015
Walk for Montreal
The student team from the GCRC along with Dr. Morag Park, Director and Dr. Peter Siegel, Associate Director joined the Walk for Montreal  with the Faculty of Medicine.
Staff and volunteers had a great afternoon listening to music, watching the inauguration ceremony and best of all, selling The Smart Palate cookbook to participants of the walk at the MUHC Glen site.
Read more


March 26, 2015
Thomas Duchaine wins prestigious HFSPO research grant
Thomas Duchaine of the Department of Biochemistry at the Goodman Cancer Research Centre has been named the recipient of a prestigious and highly competitive Program Grant from the International Human Frontier Science Program Organization (HFSPO).
Read more


September 26, 2014
Two Faculty Members are published in Nature Reviews Cancer
Dr. Morag Park and the Goodman Cancer Research Centre community would like to congratulate Dr. Alain Nepveu   and Dr. Thomas Duchaine for their recent publications in Nature Reviews Cancer.
Publication


August 26, 2014
The GCRC Mourns the Loss of Rosalind Goodman
The Rosalind and Morris Goodman Cancer Centre and the McGill University community are mourning the passing of Rosalind Goodman, a devoted alumna, generous philanthropist, and tireless volunteer, who committed herself to energizing cancer research activities at McGill and to educating others about the disease.
Read more


June 30, 2014
Jonathan Wener is Honoured at the National Assembly
The Goodman Cancer Research Centre is happy to congratulate Jonathan Wener for the Declaration of the National Assembly in celebration of the 25th edition of Défi Canderel.

National Assembly Declaration
Défi Canderel website                   Read more


June 30, 2014
Dr. Phil Branton Named to The Order of Canada
On Monday, June 30th, the  Governor General of Canada, David Johnson announced the newly appointed members to the Order of Canada.
Among the recipients is Dr. Philip Branton, O.C. (Officer of the Order of Canada) for his leadership in the development of a national cancer research framework, and for his contributions to our understanding of tumour viruses and cell division regulation.
Govenor General of Canada News Release.
McGill Reporter News Release.


Dr. Julie St. Pierre, Goodman Cancer Research Centre

June 26, 2014
Dr. Julie St-Pierre Winner of The Maude Abbott Prize
The Goodman Cancer Research Centre (GCRC) is delighted to announce that Dr. Julie St. Pierre has won the 2014 Maude Abbott Prize, awarded by the Faculty of Medicine, McGill University.
Established in 2010, the Maude Abbott Prize recognizes outstanding female Faculty Members who excel in Education, Research or Administration with a focus at the early career stage.
The faculty, staff and trainees of the GCRC extend their heartfelt congratulations to Dr. St-Pierre for receiving this honour.

 


Dr. Julie St. Pierre, Goodman Cancer Research Centre

June 26, 2014
How a Test can Help Treat each Cancer Patient the Right Way
The GCRC Breast Cancer Start-Up Challenge team, ProVivoX, has launched its crowdfunding initiative. Its goal is to create a test that will help cancer patients minimize undesired side effects of chemotherapy and maximize their quality of life. This innovative prognostic cancer test wil better predict patient survival and therapy response, key factors in personalized medicine. Visit the ProVivoX website to learn more about this initiative.

 


Young Women in Biology Planting the Seeds of Science

March 24, 2014
Young Women in Bio
This year, the Goodman Cancer Research Centre paired up with the Young Woman in Bio – Greater Montreal Chapter to help introduce young girls to the importance of studying science.
On March 24, 2014 girls from Sacred Heart School of Montreal visited the Goodman Cancer Research Centre to learn about the important place women have in science, the basic cancer research done at the Centre, the many fascinating discoveries and, of course, the potential future careers. A dedicated group of graduate students took their time to meet with the students , show them research laboratories, and involved them in scientific experiments. Everyone had a blast. The day finished with a pizza lunch which provided an opportunity to answer many questions. Many thanks to our young scientists Alyssa (PhD), Juliana (PhD), Sylvia (MSc), Ruby (PhD), Laura (MSc) and Azadeh (RA) for being great mentors.


Goodman Cancer Research Centre, La Vie en Rose

February 3, 2014
La Vie en Rose Donates $12,500 to the GCRC
The GCRC is very grateful to La Vie en Rose for its generous donation to basic cancer research.
La Vie en Rose, through its Roses of Hope Foundation, made 9 donations across Canada totalling $60,000 in time for World Cancer Day.

Photo
Press Release


Dr. Nahum Sonenberg, Goodman Cancer Research Centre

Friday, January 17, 2014
2014 Wolf Prize Awarded to Dr. Nahum Sonenberg
It is with great honor and pride that the Goodman Cancer Research Centre recognizes an incredible achievement of one of our own scientists, Dr. Nahum Sonenberg, who is a co-recipient of the 2014 Wolf Prize in Medicine.

This prestigious award has been held by many renowned scientists, who have gone on to be recipients of the Nobel Prize. Dr. Sonenberg shares the prize with two American Scientists for his seminal contributions to the field of mRNA translation, which has important implications for a variety of pathological conditions, including cancer. In fact, the biochemical pathways that have been worked out in Dr. Sonenberg’s laboratory have paved the way for numerous anti-cancer agents that are currently being developed for the management of this disease.

We extend our congratulations to Nahum on this well-deserved recognition.

CBC News Article
Times of Israel Article
McGill Reporter Article


November 12, 2013
Dr. Michel L. Tremblay Awarded The Prix Armand-Frappier 2013
We are proud to announce that Dr. Michel L. Tremblay has received the prestigious prix du Québec, Armand-Frappier award.

Each year, the government attributes five prix du Québec awards in the scientific field and six in the cultural field. The purpose of this tribute is to recognize the career of women and men who have demonstrated a passion for their calling. Individuals who have stood out by their creative or innovative spirit and whose work has contributed to the influence of Québec around the world and to the evolution of Québec society in their respective fields.

Please join us in congratulating our esteemed colleague for his outstanding achievements and its acknowledgement through the receipt of this award.
Michel continues to inspire and set an example of scientific excellence for all of us at the Goodman Cancer Research Centre.


Dr. Nahum Sonenberg, Goodman Cancer Research Centre

September 6, 2013
Nahum Sonenberg Awarded The Mclaughlin Medal from The Royal Society of Canada
We are proud to announce that The Royal Society of Canada has awarded the prestigious gold plated silver McLaughlin Medal to Dr. Sonenberg on September 6, 2013. The Royal Society of Canada is the senior national academy of distinguished Canadian scholars, artists and scientists. The McLaughlin Medal honors sustained excellence in medical science. We are delighted that Dr. Nahum Sonenberg’s work on the control of protein synthesis in cancer, autism, learning and memory and microRNA function has been awarded this prestigious honor. We extend our heartfelt Congratulations!

Royal Society of Canada Medals and Awards